Neuromodulation Devices Market Size, Growth, and Trends | 2030
Perspectivas del mercado y visión del analista:
El informe incluye perspectivas de crecimiento junto con las tendencias actuales del mercado de dispositivos de neuromodulación y su impacto previsible durante el período de pronóstico.
El uso de la neuromodulación está creciendo rápidamente, con una amplia gama de métodos implantables y no invasivos basados en tecnología para el tratamiento de trastornos neuropsiquiátricos y neurológicos. Terapias como la estimulación cortical intracraneal (ICS), la estimulación magnética transcraneal (TMS), la estimulación cerebral profunda (DBS) y la estimulación transcraneal de corriente directa (tDCS) han mostrado resultados prometedores en una variedad de trastornos neuropsiquiátricos y neurológicos. Los dispositivos de neuromodulación son instrumentos médicos avanzados que pueden ajustar la actividad del sistema nervioso. La tecnología se utiliza para tratar trastornos del movimiento como distonía, enfermedad de Parkinson, temblores; tinnitus; trastorno obsesivo compulsivo; discapacidades sensoriales; epilepsia; control de la vejiga; dolor de cabeza; dolor crónico; ataque; estado mínimamente consciente; espasticidad; y lesión de la médula espinal. Factores como el aumento de casos de lesión de la médula espinal y la creciente prevalencia de trastornos neurológicos contribuyen al creciente tamaño del mercado de dispositivos de neuromodulación.
Impulsores del mercado:
La población geriátrica es susceptible a enfermedades neurológicas. Los trastornos neurológicos comunes que afectan a las personas mayores son la neuropatía, la enfermedad de Parkinson, la enfermedad de Alzheimer, la distonía y otros. Según el Departamento de Asuntos Económicos y Sociales de las Naciones Unidas, en 2022, en todo el mundo había 771 millones de personas de 65 años o más. Se prevé que la población de edad avanzada alcance los 994 millones en 2030 y los 1.600 millones en 2050. Países como Estados Unidos y Canadá tienen altas tasas de prevalencia de trastornos del movimiento y trastornos psiquiátricos asociados con poblaciones geriátricas en crecimiento. Según la Fundación de Parkinson, los síntomas de Parkinson son comunes a una edad promedio de 60 años.
La Asociación Canadiense de Psicología afirma que el trastorno obsesivo-compulsivo (TOC) afecta aproximadamente al 2% de la población en Canadá. La Organización Mundial de la Salud (OMS) afirma que la epilepsia es un trastorno neurológico que causa convulsiones y que afecta a unos 50 millones de personas en todo el mundo. Según la Academia Estadounidense de Neurología, el accidente cerebrovascular es la tercera causa de muerte en los EE. UU., seguida por el Alzheimer como la sexta causa de muerte. Las estadísticas de la misma fuente muestran que casi un millón de estadounidenses se ven afectados por el Parkinson y cada año se reportan al menos 60.000 nuevos casos. La creciente prevalencia de enfermedades neurológicas, junto con trastornos relacionados con el estilo de vida, como la depresión y el dolor crónico, conduce a la creciente adopción de productos tecnológicamente avanzados.
Por lo tanto, la creciente población geriátrica propensa a enfermedades neurológicas, aumenta la prevalencia de las enfermedades. y la creciente conciencia sobre la tremenda carga de los trastornos neurológicos impulsan el crecimiento del mercado de dispositivos de neuromodulación.
La neurociencia se centra en el tratamiento de trastornos como accidentes cerebrovasculares, dolores de cabeza, esclerosis múltiple y otros casos graves. En los últimos años, se ha observado una relativa escasez de mano de obra neurológica cualificada incluso en los países desarrollados. En Estados Unidos hay más de 5.700 hospitales; sin embargo, estos hospitales tienen menos de 3700 neurocirujanos. Un factor importante responsable de la insuficiencia de la fuerza laboral neuroquirúrgica es la incapacidad de producir neurocirujanos adecuadamente capacitados en un período de tiempo adecuado. En las zonas urbanas se encuentran disponibles instalaciones de neurología con tecnología avanzada. Sin embargo, en las zonas rurales se ofrecen tratamientos limitados debido a la escasez de profesionales expertos. Por lo tanto, la escasez de neurocirujanos capacitados obstaculiza el crecimiento del mercado de dispositivos de neuromodulación.
Segmentación y alcance del informe:
Se ha llevado a cabo el “análisis de mercado de dispositivos de neuromodulación” considerando los segmentos: tipo, aplicación, biomaterial y usuario final.
Análisis segmentario:
El mercado de dispositivos de neuromodulación, por tipo, se bifurca en externo e interno. El segmento de neuromodulación interna tuvo una mayor participación de mercado de dispositivos de neuromodulación en 2022. Sin embargo, es probable que el segmento de neuromodulación externa registre una CAGR más alta durante 2022-2030. El término "neuromodulación interna" describe el uso de dispositivos médicos que proporcionan estimulación eléctrica, química u otras formas de estimulación neuronal específica para modular o alterar la actividad del sistema nervioso. Esta técnica se utiliza para tratar enfermedades neurovasculares, anomalías del movimiento, epilepsia, dolor crónico e incontinencia fecal y urinaria.
Mercado de dispositivos de neuromodulación, por tipo: 2022 y 2030
Por usuario final, el El mercado de dispositivos de neuromodulación está segmentado en hospitales, clínicas y atención médica domiciliaria. En 2022, el segmento de hospitales dominó la cuota de mercado de dispositivos de neuromodulación. Debido a la expansión de numerosos hospitales y clínicas y al aumento del gasto gubernamental para construir infraestructura sanitaria, el segmento de hospitales domina actualmente el mercado. Además, se espera que el envejecimiento de la población dé como resultado una mayor prevalencia de dolor crónico, lo que impulsará la demanda de dispositivos de neuromodulación en los hospitales.
Análisis regional:
El alcance del informe de mercado de dispositivos de neuromodulación es segmentado principalmente en América del Norte (EE. UU., Canadá y México), Europa (España, Reino Unido, Alemania, Francia, Italia y el resto de Europa), Asia Pacífico (Corea del Sur, China, India, Japón, Australia y el resto de Asia Pacífico), Medio Oriente y África (Sudáfrica, Arabia Saudita, Emiratos Árabes Unidos y el resto de Medio Oriente y África) y América del Sur y Central (Brasil, Argentina y el resto de América del Sur y Central). ).
En términos de ingresos, América del Norte dominó la cuota de mercado de dispositivos de neuromodulación en 2022. La creciente prevalencia de enfermedades neurológicas, el alto gasto en investigación y desarrollo, el creciente número de aprobaciones de productos por parte de la FDA y los avances tecnológicos impulsar la demanda de dispositivos de neuromodulación en la región.
Panorama competitivo y empresas clave:
El informe de mercado de dispositivos de neuromodulación se centra en actores destacados del mercado como Abbott (St. Jude Medical, Inc), LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioventus, EnteroMedics Inc, Nevro Corporation, NeuroPace Inc, Synapse Biomedical Inc y Neurosigma Inc. El pronóstico del mercado de dispositivos de neuromodulación puede ayudar a las partes interesadas a planificar sus estrategias de crecimiento. Estas empresas se centran en nuevas tecnologías, la actualización de productos existentes y la expansión del mercado para satisfacer la creciente demanda de los consumidores en todo el mundo. Según los comunicados de prensa de la empresa, a continuación se presentan algunos desarrollos clave recientes:
En agosto de 2023, Medtronic plc recibió la aprobación de la marca CE para su estimulador de médula espinal (SCS) recargable de circuito cerrado Inceptiv. Es el primer dispositivo SCS de Medtronic que ofrece una función de circuito cerrado que detecta las señales biológicas únicas de cada persona y ajusta la estimulación momento a momento, según sea necesario, para mantener la terapia en armonía con los movimientos de la vida diaria. En agosto de 2023, Abbott recibió la aprobación. de la Administración de Medicamentos y Alimentos de EE. UU. (FDA) por su nuevo sistema de estimulación de la médula espinal (SCS) Proclaim Plus que incluye la terapia FlexBurst360. La próxima generación de estimulación BurstDR patentada por Abbott, la terapia FlexBurst360, ofrece cobertura del dolor en seis áreas del tronco y/o las extremidades. Facilita una programación que se puede ajustar según las necesidades terapéuticas de una persona.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The neuromodulation device market, based on end user, segmented into hospitals, clinics, and home healthcare. In 2022, the hospitals segment dominated the neuromodulation devices market share.
Asia Pacific is expected to be the fastest growing region in the neuromodulation device market. The rising prevalence of neurological diseases and the development of neuromodulation devices are likely to enhance the market's growth in the coming years. China is among the most populated countries in the world, and the country has a maximum number of patients suffering from neurological disorders.
The neuromodulation device market, based on application, is segmented into metallic, polymeric, and ceramic. In 2022, the metallic segment dominated the market share. However, the polymeric segment is likely to register the highest CAGR during 2022–2030.
The neuromodulation device market, based on application, is segmented into deep brain stimulation (DBS), sacral nerve stimulation (SNS), gastric electrical stimulation (GES), spinal cord stimulation (SCS), and vagus nerve stimulation (VNS). The spinal cord stimulation segment held the largest market share in 2022 and is expected to record the highest CAGR in the market during 2022–2030.
The neuromodulation device market, based on type, is bifurcated into external and internal. The internal neuromodulation segment held a larger neuromodulation devices market share in 2022. However, the external neuromodulation segment is likely to register a higher CAGR during 2022–2030.
US holds the largest market share in neuromodulation device market. the incidence of neurovascular diseases is rising significantly, and it is among the leading causes of death across the country. Rising incidence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, and growing investments in developing transcranial stimulators are among the main factors driving the overall neuromodulation devices market growth in the US.
The neuromodulation device market majorly consists of the players such as Abbott (St. Jude Medical, Inc.), LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, Bioventus, EnteroMedics Inc, Nevro Corporation, NeuroPace Inc, Synapse Biomedical Inc, Neurosigma Inc among others.
The factors that are driving growth of the market are the rising cases of spinal cord injury and increasing prevalence of neurological disorders.
Neuromodulation use is growing rapidly, with a wide range of implantable and noninvasive technology-based methods for the treatment of neuropsychiatric and neurological disorders. Therapies such as intracranial cortical stimulation (ICS), transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and transcranial direct current stimulation (tDCS) have shown promising results across a range of neuropsychiatric and neurological disorders. Neuromodulation devices are advanced medical instruments that can adjust the activity of the nervous system. The technology is used to treat movement disorders such as dystonia, Parkinson’s disease, and tremor; tinnitus; obsessive compulsive disorder; sensory disabilities; epilepsy; bladder control; headache; chronic pain; stroke; minimally conscious state; spasticity; and spinal cord injury.
The List of Companies - Neuromodulation Devices Market
- Abbott (St. Jude Medical, Inc.)
- LivaNova PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Bioventus
- EnteroMedics Inc.
- Nevro Corporation
- NeuroPace Inc.
- Synapse Biomedical, Inc.
- Neurosigma, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For